Pharmacoeconomic Aspects in the Treatment of Curable and Incurable Cancer
- 1 October 1995
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 8 (4) , 275-281
- https://doi.org/10.2165/00019053-199508040-00002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodesEuropean Journal Of Cancer, 1994
- Quality of Life Measures in Cancer ChemotherapyPharmacoEconomics, 1994
- Cost-utility analysis.BMJ, 1993
- Palliative care of patients with terminal cancerCurrent Opinion in Oncology, 1993
- Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trialCancer, 1993
- Therapeutic SubstitutionPharmacoEconomics, 1993
- Quality-adjusted Life Years, Utility Theory, and Healthy-years EquivalentsMedical Decision Making, 1989
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI Journal of the National Cancer Institute, 1989
- The use of QALYs in health care decision makingSocial Science & Medicine, 1989
- Utility approach to measuring health-related quality of lifeJournal of Chronic Diseases, 1987